Patrick Cox is at it again with some teaseriffic promises — this time, we’re told that … “This is a Rare Opportunity to Own a Little-Known Biotech Company that’s Making Medical History…” Of course, nearly everything that passes through the floodgates here at Gumshoe HQ is a “rare opportunity” … otherwise, why on earth would […]
Articles
- Most Relevant
- Most Recent
Michael Robinson has been pitching “Living Metal” again recently, as an add-on to some of his ads for Nova-X Report over the last few weeks, so I thought I’d take another look at it for you. This is no longer the centerpiece of any promo campaigns that I can see, it was mentioned late in […]
This next teaser stock, we’re told … “Is Proof One Doctor Can Grow New Organs, Regenerate Limbs, and Eradicate Disease “And you can buy shares of his company right now, before anyone else knows it exists.” The tease is to get you to subscribe to Steve Christ’s newsletter, The Wealth Advisory — I’ve written about […]
[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]
Several intrepid readers sent this pitch flying my way while we were digging out of our latest snowstorm, and I figured a nice little panic about an $82 billion “missed opportunity” ought to warm me up. Phase 1 Investor, the big “upgrade” letter from Stansberry & Associates, usually gets our readers attention when they send […]
[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice. As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]
I haven’t written about any teasers from Dr. Stephen Leeb lately, but this one caught my eye — he’s got not only a made up term for an investment (the “MCR Plan”), but also a made-up term for how you’ll profit from it (“Income Stacking”). So the great readers of Gumshoedom have asked for answers, […]
I’m going to get to several updates on Real Money Portfolio stocks at the end, including those questions “What to do with Qualcomm (QCOM)?” … but first, I’m going to go through the stocks where I’ve completed my Annual Review this week. Each year I promise to re-analyze and reconsider my opinion about each stock […]
[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, writes for us a couple times a month on medicine and health issues. He is not a physician, but explains the science and the data well, and helps provide some background understanding and perspective that often benefits both investors and folks who are attentive […]
This here one is an oldie but a goodie — it’s one that I sniffed out back in April, when but a few courageous souls were following the Gumshoe’s exploits. Now that readership here has exploded tenfold or more, and this teaser ad, virtually word for word, has recently started making the rounds again, I […]
Many of the delightful readers of Gumshoe Nation have sent in this ad, for the True Income service from Stansberry & Associates. As with so many ads these days, it teases us that, (if we’ll just subscribe and follow their advice), we can make tremendous profits with lower risk. Here’s how it opens: “Can “Mega-Bond” […]
Several readers have asked me this week what “Dividend Superstations” are… so that’s the target for the Thinkolator today. The ad comes from Brett Owens for his Contrarian Income Report, which is usually sold as a service that looks for a “secure 8% ‘no withdrawal’ return” for retirement — an admirable goal, and not terribly […]
Mitchell Clark edits Passive Monthly Income for Lombardi, and an ad of theirs this week promises great gains from “PRIP” investments… … so, naturally, we want to know what those are. Right? I don’t know if we want to subscribe to Passive Monthly Income or not, that’s one of dozens of newsletters published by Lombardi, […]
“On June 15th, 2009, Dayton Superior Corp. is required by federal law to pay investors a 97% ‘Scheduled Distribution’ … “Right now, more than 100 companies are issuing abnormally large, 1-day payouts to their investors … “And while most companies are cutting their dividends – or doing away with them entirely – these ‘Scheduled Distributions’ […]
I’ve had a couple readers ask about this one, and it seems fairly interesting, so I thought I’d look into it even though it doesn’t seem to have been particularly actively promoted. The “tease” came in Steve Sjuggerud’s free Daily Wealth newsletter over the weekend, as bait to tempt subscribers into his True Wealth newsletter […]
These kinds of ads always include some huge numbers that sound really, really impressive… here’s a little bit of the intro from the latest ad for Briton Ryle’s The Wealth Advisory: “*Jim T. collected $23,500 last month from ‘backdooring’ Google’s Account *Ron J. ‘backdoored’ $15,804 from Facebook’s Account *Aaron K. pocketed $6,817 last month from […]
Nobody likes a monopoly… except investors, of course. We love monopolies, as long as we can own shares. There’s almost nothing better than a lack of competition, because that gives pricing power and better margins and a nice steady stream of profits. And if you can own a monopoly company that also pays out a […]
“It doesn’t involve Stocks… Government Bonds… Currencies… or even Options.” Steve McDonald wants to sell us a service that will help select safe investments. The ad says that “back testing the strategy to 1920 proved that it was 99.77% risk-free.” Is that kind of return really possible … or, more importantly, is it likely? And what is he talking about?
Regular investors are getting interested in gold again, after the big run it had in the first half of this year… and many of us also remember the ludicrous returns that many folks got from buying bitcoin early on… so it’s only natural that this ad puts our greed receptors into overdrive: “The time to […]
Ok, this is definitely the “most requested” ad over the last 24 hours — I can’t tell you how many folks have asked your friendly neighborhood Gumshoe to look into “Living Metal,” but the list is getting loooong. And we are, of course, happy to oblige. The pitch is from Michael Robinson for his Radical […]
This article was originally published in February, the ad is recirculating with minor updates (mostly that the “deadline” is now April 1, versus previous versions that cited January 1 or February 1), so we’re re-sharing this piece to help answer continuing reader questions. What appears below has not been updated since 2/7/18. I’m sure quite […]
So… what’s been happening to the Real Money Portfolio stocks this week? What else caught my eye? No transactions this week, but plenty of stuff to think about… Clean TeQ Holdings (CLQ.AX, CLQ.TO, CTEQF) announced a somewhat surprising equity raise a couple days ago. It seems inspired largely by urgency — they can’t really claim […]
I’ve had a couple readers ask about this one, and it seems fairly interesting, so I thought I’d look into it even though it doesn’t seem to have been particularly actively promoted. The “tease” came in Steve Sjuggerud’s free Daily Wealth newsletter over the weekend, as bait to tempt subscribers into his True Wealth newsletter […]
Rickards says, that in a couple of months the President will up-boot the dollar. He says gold prices must rise significantly, but gold is not where we should be invested when this happens for the greatest gains. Can y’all inform me what that investment is, and whether their is any truth to Rickards prediction and […]
Pretty much every publisher has jumped on the cryptocurrency bandwagon, and this latest one shouldn’t come as much of a surprise… Jim Rickards has styled himself as a currency guru, with his “Currency Wars Alert” and plenty of pitches about the impending demise of the dollar or other major currency moves in recent years, and […]
High end newsletter with monthly cryptocurrency trading recommendations, first crypto “token” recommendation made in January 2018. Rickards has previously helmed many newsletters that focus on gold and currency trading.
Wondering if anyone has heard Jim Rickard’s spiel on the $0.70 Cryptocurrnecy that is backed by IBM and is set to shoot higher? Sounds like another way to work on folks fear of missing outand getting them to pony up $2000 for another newsletter…”Crypto Profits.” Any idea what the IBM backed Crypto is?
This is a bonus weekend “quickie” for you, so it’s not a stock I’m going to go in depth on… but I thought you might want a few moments to think about it while the market’s not open. The promise is absurd, here’s a taste of it from the top of the ad: “ALERT: Agora […]
He keeps changing the date of this turmoil, but I’m curious as to what he claims you can protect your money and profit from it. Thanks Travis.
In an email from Rickards today (jan. 19) he says he will reveal his only crypto recommendation tomorrow. I figure if I knew what it was I could beat the stampede.
No, Balthasar is not a biotech company. Think fast! Aragorn, Legolas and Gimli. Athos, Porthos and Aramis. Jaclyn, Farrah and Kate. Kirk, Spock and Bones. Barry, Robin and Maurice. Shadrach, Meshach and Abednego. History and culture bestow trios upon us because threesomes keep us rapt. The Three Magi, liking the Gummune as they do, have […]
proposition to watch for green lights (an indication of an explosive move on a stock) or a red light ( a negative move is coming on the stock. The cost goes from 3,000 down to $2.000 with a guarantee of 1 free year . It sounds interesting but his history is questionable, Thanks Travis.
There’s a clear winner in the “what readers are asking about” sweepstakes this morning, and it’s the latest pitch from Charles Mizrahi for his Park Avenue Investment Club (currently $99/yr) — so that ad must really be making the rounds, and we’ll fire up the Thinkolator to get you some answers today. The pitch is […]
Hey Travis, I received this in an email this morning and was wondering if you know the stock. Thanks! Craig Now, a promise like this would be preposterous coming from anyone else … however, when a person with Paul’s credentials comes forward, one is practically required to pay attention. After all, Paul’s $6 billion hedge […]
[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]
[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues and trends. He does not typically focus on specific investment opportunities, but has agreed to our trading restrictions… as with all of our authors, […]
This article originally appeared on September 14, when the teaser pitch was circulating with a September 15 “deadline” to get your “extra $1,003 a month in benefits.” We’re getting a lot of questions about it again, so we’re republishing this article… other than the move to a December 15 “deadline,” the ad appears unchanged (and […]
Has anyone seen this recent offering from Agora or got any experience of the service, supposedly underpinned by big-data analytics software?
by a currency outside of our country’s control and Trump can’t do a thing about it. Retirees who don’t act will stand to lose basically everything, Disruption in social security payments, medicare along with everything else . Any chance of what this doomsayer is calling for can anything be done to avoid this? Or is […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He’s agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see his past articles and most recent comments here.] The death of Mr. Chiang, who was always kind, has never set well […]